InterLeukin is a 2021-founded company that aims to revolutionize the healthcare supply chain with its digital procurement platform. The platform collaborates with both local and international distributors and manufacturers to provide cost-effective solutions. Through its digital tool, InterLeukin manages all procurement needs and facilitates servicing requirements to meet customer expectations. The company recently secured a $60.00K Pre Seed Round investment on 01 July 2021 from Buko Ventures and Private Investors. Their focus on E-Commerce, Health Care, Information Technology, and Medical Devices highlights the potential for growth and impact in these industries.
General Information
BounceWatch is an independent company data service, not affiliated with InterLeukin. To contact InterLeukin, visit interleukin.co.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does InterLeukin compare?
A PDF of InterLeukin and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting InterLeukin soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
E-Commerce
About InterLeukin
Funding Rounds & Investors (1)
View AllInterLeukin Alternatives & Competitors
The Global Leader in Digital Healthcare Solutions
Healthcare's Smarter Supply Chain.
FAQ About InterLeukin
Source: BounceWatch company record for InterLeukin, https://bouncewatch.com/company/interleukin, updated 27 December 2024. When citing, please name BounceWatch and link this page.